News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    
   

Bartelmez Joins Ixion Biotechnology As President, CEO; Company To Focus Only On Stem Cell Diabetes Research


10/19/2005 5:12:11 PM

ALACHUA, Fla.--(BUSINESS WIRE)--Sept. 19, 2005--Stem cell biologist and entrepreneur Stephen Bartelmez, Ph.D., has joined Ixion as president and CEO, in order to focus the Company exclusively on cellular therapy for diabetes.

Read at BioSpace.com


comments powered by Disqus
   

ADD TO DEL.ICIO.US    ADD TO DIGG    ADD TO FURL    ADD TO STUMBLEUPON    ADD TO TECHNORATI FAVORITES